ACTIVE_NOT_RECRUITING

A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This project will evaluate a proactive outreach intervention for tobacco cessation among primary care BIPOC populations who smoke in two health systems across the region. Compared with Whites, BIPOC populations in the US experience disproportionate health consequences from commercial cigarette use. Few evidence-based cessation treatments (EBCTs) have been specifically developed, evaluated, or implemented for BIPOC populations. Moreover, uptake of EBCT (e.g. medication, counseling) is lower among BIPOC populations. Reasons for the failure to engage BIPOC patients in EBCTs are complex and multi-level (e.g., patient, provider, healthcare system). To address these gaps, the investigators will assess the added effectiveness of an approach to augment the standard of care with longitudinal proactive outreach to connect BIPOC adults with EBCT. The proposed multi-level intervention leverages the electronic health record to identify patients who smoke, who can then be proactively engaged via culturally tailored outreach to connect them to EBCT. The proactive approach may circumvent experiences of bias within the healthcare system and thus enhance engagement.

Official Title

A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities

Quick Facts

Study Start:2023-05-05
Study Completion:2026-06-24
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05671380

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * English or Spanish-speaking BIPOC patients within the Hennepin Healthcare or MCHS system. BIPOC patients are any patients with a chart identified race that is not White, and will be verified by self-report from the baseline survey.
  2. * Currently smoke \>1 cigarette over the past 30 days
  3. * Must have address or telephone number in the electronic health record
  1. * Electronic health record documented cognitive impairment or legal guardianship
  2. * Patients who have opted out of reserach studies

Contacts and Locations

Principal Investigator

Steven Fu, MD, MSCE
PRINCIPAL_INVESTIGATOR
Minneapolis Veterans Affairs Medical Center

Study Locations (Sites)

Hennepin Healthcare
Minneapolis, Minnesota, 55415
United States
University of Minnesota
Minneapolis, Minnesota, 55455
United States
Mayo Clinic Health System
Rochester, Minnesota, 55902
United States

Collaborators and Investigators

Sponsor: University of Minnesota

  • Steven Fu, MD, MSCE, PRINCIPAL_INVESTIGATOR, Minneapolis Veterans Affairs Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-05-05
Study Completion Date2026-06-24

Study Record Updates

Study Start Date2023-05-05
Study Completion Date2026-06-24

Terms related to this study

Additional Relevant MeSH Terms

  • Tobacco Use Cessation
  • Cardiovascular Diseases
  • Tobacco Use
  • Smoking
  • Smoking Cessation